So far, prasinezumab has yet to notch a clear victory in clinical testing. A trial titled “PASADENA” enrolled a little over 300 participants with early Parkinson’s and compared two different doses of ...

In the study, researchers used data from more than 227,000 people in Sweden's patient data registry, a national database of health records. The study's subjects were diagnosed with alcohol use ...

Eli Lilly's Zepbound outperformed Novo Nordisk's top weight loss drug in a recent study. Both drugs showed that they were highly effective in helping people lose weight, but Zepbound's numbers ...

Besides, newer drug regimens and implementation studies are under evaluation for the potential ... was done following anti-TB treatment owing to the risk of cross-reactivity between rifampicin and ...

Vertex Pharmaceuticals Inc.’s nonaddictive drug for lower back pain didn’t do better than a placebo in a midstage trial, causing the company’s shares to fall Thursday. Vertex, based in ...

Based on the above results and subject to regulatory discussions, Sanofi and Teva intend to start a late-stage study on the drug across both UC and CD indications. The companies also plan to ...

Keros Therapeutics (NASDAQ:KROS) stock plunged 73% Thursday after the company said it has halted two arms of a Phase 2 clinical study of its drug cibotercept in patients with pulmonary arterial ...

After hours: December 26 at 6:40:23 PM EST Loading Chart for DRUG ...

A recent study found that more than 5 years of taking medications like blood pressure and lipid-lowering drugs was associated with a lower incidence of dementia. At the same time, researchers ...

Warnings have been issued over commonly prescribed drugs could increase risk of dementia following a scientific study. Research suggested that regular use of certain types of commonly-prescribed ...

plunged on Friday after it announced disappointing results of a new drug study. The drugmaker said clinical trials had demonstrated that overweight subjects using the weight-loss drug Cagrisema ...

Celeste Maycock, an emergency room physician, presented a collaborative initiative between the Bermuda Hospitals Board and the Department for National Drug Control. “This anonymous study aimed ...